Fresh analysis reveals that people who come off blockbuster weight-loss injections like Wegovy and Mounjaro may regain lost weight far faster than those who halt traditional lifestyle plans.
Research printed in a major health publication points out that while overweight people often shed a large proportion of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users buying such medications should be cognizant of the danger of rapid weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.
That rate of regain suggests a return to pre-treatment mass within about one and a half years.
Weighing Approaches
The analysis, which reviewed dozens of trials involving thousands of patients, contrasted the effects of the injectable medications with other pills.
The team point out that people who lose weight through diet and exercise typically experience a slower weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Fast Regain
Nutrition scientists propose the way of the injections accounts for the heightened weight return.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to produce less of its own natural hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' results in hunger is unsuppressed, making overeating a significant risk."
A Chronic Condition?
The NHS advise the injections for people with obesity-related health risks, alongside recommended lifestyle changes.
Professionals contend that, considering the likelihood of weight regain, the therapy should be considered life-long.
This perspective is echoed by drug manufacturers, who state that the findings "emphasize the long-term nature of excess weight," akin to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have discontinued the jabs report a intense return of cravings.
"I experienced a switch flipping and I was suddenly extremely hungry," recalled a patient.
This challenge is exacerbated if individuals have not established sustainable dietary or behavioural modifications during treatment.
Growing Adoption
Survey data show that a significant number of adults in the UK have tried these injections in the past year, with desire remaining high.
- Use is greater among females than men.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Ultimately, researchers stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic fix and lasting health benefits relies on integrated lifestyle management.
